Loading...

The Sequence Dependence of Cell Growth Inhibition by EGFR-Tyrosine Kinase Inhibitor ZD1839, Docetaxel and Cisplatin in Head and Neck Cancer

BACKGROUND: This study was to explore whether the efficacy of the EGFR tyrosine kinase inhibitor ZD1839 (Z, Iressa, gefitinib) plus chemotherapeutic agents docetaxel (D) and cisplatin (P) may benefit from sequencing of the combination. METHODS: Three head and neck cancer cell lines were used to stud...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Klass, Carmen M., Choe, Mi Sun, Hurwitz, Selwyn J., Tighiouart, Mourad, Zhang, Xin, Chen, Zhuo (Georgia), Shin, Dong M.
Format: Artigo
Sprog:Inglês
Udgivet: 2009
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3600558/
https://ncbi.nlm.nih.gov/pubmed/19399750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hed.21103
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!